Antibiotics

Metronidazole is used to treat infections of the reproductive system, gastrointestinal (GI) tract, skin, heart, bones, joints, lungs, blood, nervous system, and other areas of the body. It is also used to treat certain sexually transmitted diseases (STDs).

Metronidazole is used to treat infections of the reproductive system, gastrointestinal (GI) tract, skin, heart, bones, joints, lungs, blood, nervous system, and other areas of the body. It is also used to treat certain sexually transmitted infections (STIs).

Broad-spectrum beta-lactam antibiotic indicated for pharyngotonsillitis, sinusitis, otitis, bronchitis, gastroenteritis, typhus fever, pyelonephritis, skin infections, and other infections caused by ampicillin-sensitive bacteria. Therapeutic Indications: Ampicillin ENT, respiratory, dental, gastrointestinal, genitourinary, skin and soft tissue, neurological, surgical, trauma, bacterial meningitis, and septicemia.

Therapeutic indications Ampicillin ENT, respiratory, dental, gastrointestinal, genitourinary, skin and soft tissue, neurological infections, surgery, trauma, bacterial meningitis, and sepsis. Administration Ampicillin Oral forms should be administered with a large glass of water on an empty stomach (1 hour before or 2 hours after).

NALIXONE TABLETS 500MG/50MG Treatment of urinary tract infections and associated symptoms caused by Gram-negative microorganisms susceptible to nalidixic acid, including Klebsiella, Enterobacter, E. coli, and most Proteus strains.

This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (e.g., middle ear, urinary tract, respiratory, and intestinal infections). It is also used to prevent and treat certain types of pneumonia (pneumocystis). It has a moderately broad antibacterial spectrum, acting on gram-positive cocci and aerobic gram-negative cocci and bacilli, especially Enterobacteriaceae.

Adults, treatment of: pyelonephritis and complicated urinary tract infections, chronic bacterial prostatitis, uncomplicated cystitis, inhalational anthrax (treatment and post-exposure prophylaxis). Treatment, when recommended antibacterials are inappropriate, of: acute bacterial sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated skin and soft tissue infections.

Therapeutic Indications Clarithromycin - Oral, in normal-release and modified-release forms: Adults and children ≥12 years: pharyngitis, tonsillitis, sinusitis (diagnosed), acute bronchitis, acute exacerbation of chronic bronchitis, bacterial pneumonia (community-acquired), mild-to-moderate skin and soft tissue infections, folliculitis, cellulitis, erysipelas. - Oral, in normal-release forms: Adults and children ≥12 years: localized or disseminated M. avium or M. intracellulare infection, localized M. chelonae, M. fortuitum, and M. kansaii infection, gastric or duodenal ulcer associated with H. pylori (with an appropriate antiulcer agent). Prevention of disseminated M. avium complex infection in high-risk HIV patients (CD4 lymphocytes ≤ 50/mm 3 ). Children > 12 months to 11 years: streptococcal pharyngitis, bacterial bronchitis and pneumonia, acute otitis media, impetigo, folliculitis, cellulitis, abscesses. - IV: Adv.: Parenteral treatment for streptococcal pharyngitis or tonsillitis if first-line treatment with beta-lactams is not possible or there is demonstrated sensitivity to S. pyogenes; diagnosed acute bacterial sinusitis; acute exacerbation of chronic bronchitis; mild-moderate skin and soft tissue infections if beta-lactams are not appropriate. It is a macrolide antibiotic with bactericidal action and is effective against a wide range of aerobic and anaerobic bacteria, as well as gram-positive and gram-negative bacteria. It is used for upper and lower respiratory tract infections, skin and soft tissue infections, and infections caused by the Mycobacterium complex (M.

Amifarin (Dicloxacillin) is a semi-synthetic antibiotic of the penicillin family, indicated for the treatment of bacterial infections caused by organisms sensitive to dicloxacillin. Each bottle contains 60 ml of powder for oral suspension, equivalent to 250 mg/5 ml of dicloxacillin. This medicine is only available with a medical prescription. Wandel Laboratory

AMIKACIN-AMSA INJECTION 500 Amikacin injection belongs to a class of medications called aminoglycoside antibiotics. It works by eliminating bacteria. Antibiotics such as amikacin injection do not work against colds, influenza, or any other viral infection. C/1 Therapeutic Indications Amikacin Short-term treatment of serious infections caused by gram-sensitive microorganisms: Pseudomonas, E. coli, Proteus (indole-positive and indole-negative), Providencia, Klebsiella, Enterobacter, Serratia, and Acinetobacter (Mima-Herellea). Short-term treatment of serious infections caused by susceptible strains of microorganisms such as: septicemia (including neonatal sepsis); severe respiratory tract infections; CNS infections (meningitis); intra-abdominal infections (including peritonitis); complicated and recurrent urinary tract infections, where treatment is not possible with other less toxic antibiotics; Skin, bone, soft tissue, and joint infections; burn infections; postoperative infections (including post-vascular surgery).

Therapeutic Indications Cefaclor Otitis media due to: S. pneumoniae, H. influenzae, staphylococci, S. pyogenes, and M. catarrhalis; lower respiratory tract infection, pneumonia due to: S. pneumoniae, H. influenzae, S. pyogenes, and M. catarrhalis; upper respiratory tract infection, pharyngitis and tonsillitis due to: S. pyogenes and M. catarrhalis; urinary tract infection, cystitis and pyelonephritis due to: E. coli, P. mirabilis, Klebsiella, and coagulase-causing staphylococci; skin and soft tissue infection due to: S. aureus and S. pyogenes. Sinusitis. Gonococcal urethritis. Laboratorios Maver

Useful in the treatment of respiratory tract infections, bacterial sinusitis, otitis media, skin and soft tissue infections, bone and joint infections, genitourinary tract infections, including acute prostatitis, and dental infections.

Clarithromycin is useful for the treatment of: Upper respiratory tract infections (tonsillitis, pharyngitis, sinusitis, otitis). Lower respiratory tract infections (bronchitis, pneumonia). Therapeutic indications for Clarithromycin: - Oral, in immediate-release and modified-release formulations: Adults and children ≥12 years: pharyngitis, tonsillitis, sinusitis (diagnosed), acute bronchitis, acute exacerbation of chronic bronchitis, bacterial pneumonia (community-acquired), mild-to-moderate skin and soft tissue infections, folliculitis, cellulitis, erysipelas. - Oral, in immediate-release formulations: Adults and children ≥12 years: localized or disseminated infection caused by M. avium or M. intracellulare, localized infection caused by M. chelonae, M. fortuitum, and M. kansaii. Gastric or duodenal ulcer associated with H. pylori (in conjunction with appropriate anti-ulcer medication). Prevention of disseminated M. avium complex infection in high-risk HIV patients (CD4 lymphocytes ≤ 50/mm³). Children > 12 months to 11 years: streptococcal pharyngitis, bacterial bronchitis and pneumonia, acute otitis media, impetigo, folliculitis, cellulitis, abscesses. - IV: Adults: parenteral treatment of streptococcal pharyngitis or tonsillitis if first-line treatment with beta-lactams is not possible or there is demonstrated susceptibility to S. pyogenes; diagnosed acute bacterial sinusitis; acute exacerbation of chronic bronchitis; mild-to-moderate skin and soft tissue infections if beta-lactams are not appropriate.

Therapeutic Indications Clarithromycin - Oral, in immediate-release and modified-release formulations: adults and children ≥12 years: pharyngitis, tonsillitis, sinusitis (diagnosed), acute bronchitis, acute exacerbation of chronic bronchitis, bacterial pneumonia (community-acquired), mild-to-moderate skin and soft tissue infections, folliculitis, cellulitis, erysipelas. - Oral, in immediate-release formulations: adults and children ≥12 years: localized or disseminated infection caused by M. avium or M. intracellulare, localized infection caused by M. chelonae, M. fortuitum, and M. kansaii. Gastric or duodenal ulcer associated with H. pylori (in conjunction with an appropriate anti-ulcer agent). Prevention of disseminated M. avium complex infection in high-risk HIV-positive patients (CD4 lymphocytes ≤ 50/mm³). Children > 12 months to 11 years: streptococcal pharyngitis, bacterial bronchitis and pneumonia, acute otitis media, impetigo, folliculitis, cellulitis, abscesses. - IV: Adults: parenteral treatment of streptococcal pharyngitis or tonsillitis if first-line treatment with beta-lactams is not possible or there is demonstrated susceptibility to S. pyogenes; diagnosed acute bacterial sinusitis; acute exacerbation of chronic bronchitis; mild-to-moderate skin and soft tissue infections if beta-lactams are not appropriate.

Gentamicin injection is in a class of drugs called aminoglycoside antibiotics. It works by killing bacteria. Gentamicin is indicated for the following conditions: 1. Gastrointestinal infections. 2. Genitourinary infections and kidney infections. 3. Septicemia. 4. Peritonitis or pelvic infections. 5. Intra-abdominal infections. 6. Skin, soft tissue, and bone infections. 7. Eye infections. 8. Infected wounds and burns. 9. Bone and joint infections. In these conditions, there must be suspicion or certainty that the causative germ is a gram-negative bacterium such as Pseudomona aeruginosa, E. coli, Proteus, Klebsiella, Enterobacter, Serratia, Citrobacter, Staphylococcus (coagulase-positive or coagulase-negative) or Neisseria gonorrhoeae. Gentamicin has been used effectively when associated with carbenicillin for serious infections caused by Pseudomona aeruginosa.

ENT, respiratory, dental, gastrointestinal, genitourinary, skin and soft tissue, neurological, surgical, trauma, bacterial meningitis and sepsis infections.